Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.

Neurology Today in 5
20/07/2023 5 min
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.

Listen "Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas."

Descargar episodio Ver en sitio original

Episode Synopsis

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.

More episodes of the podcast Neurology Today in 5

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia 06/11/2025
Novel PET radiotracer, GLP-1s and dementia risk, green space benefits 16/10/2025
Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists 02/10/2025
Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine 18/09/2025
Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG 04/09/2025
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists 21/08/2025
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America" 07/08/2025
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine 17/07/2025
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia 03/07/2025
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. 19/06/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA